Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography

Objective To compare the retinal microcirculation in Crohn’s disease cases under infliximab (IFX) biosimilar with controls that are age- and sex-matched in terms of disease severity. Background Crohn’s disease is a relapsing, remitting condition that affects the gastrointestinal tract. One approach...

Full description

Saved in:
Bibliographic Details
Main Authors: Hesham M. El Mazar, El sayed E. El Shayeb, Asmaa M. Ebrahim, Ayatullah S.A. Motawe, Esraa S. El-Ghoubashy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-01-01
Series:Journal of the Egyptian Ophthalmological Society
Subjects:
Online Access:https://journals.lww.com/10.4103/ejos.ejos_33_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199240468496384
author Hesham M. El Mazar
El sayed E. El Shayeb
Asmaa M. Ebrahim
Ayatullah S.A. Motawe
Esraa S. El-Ghoubashy
author_facet Hesham M. El Mazar
El sayed E. El Shayeb
Asmaa M. Ebrahim
Ayatullah S.A. Motawe
Esraa S. El-Ghoubashy
author_sort Hesham M. El Mazar
collection DOAJ
description Objective To compare the retinal microcirculation in Crohn’s disease cases under infliximab (IFX) biosimilar with controls that are age- and sex-matched in terms of disease severity. Background Crohn’s disease is a relapsing, remitting condition that affects the gastrointestinal tract. One approach to management is to use biological therapy. Patients and methods This cross-sectional case-control study was carried out at the outpatient clinic of the gastroenterology and hepatology departments of the Faculty of Medicine at Menofia University and was imaged at Shebin Elkom Ophthalmology Hospital. The study included 60 participants who were divided into three groups with no ophthalmologic history or symptoms. Results Regarding slit examination findings, within group A 14 (70%) cases had eye dryness, and six (30) had allergic keratoconjunctivitis; within group B 11 (55%) cases were normal, five (25%) cases showed dryness, and three (15%) had allergic keratoconjunctivitis; and there was anterior uveitis in one (5%) patient; in group C 10 (50%) patients were normal, seven (35%) patients showed dryness, and three (15%) had allergic keratoconjunctivitis. There was a significant increase in dryness and allergic keratoconjunctivitis within group A compared with groups B and C (P=0.04). Conclusion Our study concluded that patients with moderate to severe Crohn’s disease who received IFX biosimilar had higher eye dryness, allergic keratoconjunctivitis, and longer disease duration. Therefore, the use of IFX should be limited.
format Article
id doaj-art-2aafa31c9d1641b6835dad77cbf1115a
institution Kabale University
issn 2090-0686
language English
publishDate 2025-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of the Egyptian Ophthalmological Society
spelling doaj-art-2aafa31c9d1641b6835dad77cbf1115a2025-02-08T05:26:23ZengWolters Kluwer Medknow PublicationsJournal of the Egyptian Ophthalmological Society2090-06862025-01-011181313610.4103/ejos.ejos_33_24Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiographyHesham M. El MazarEl sayed E. El ShayebAsmaa M. EbrahimAyatullah S.A. MotaweEsraa S. El-GhoubashyObjective To compare the retinal microcirculation in Crohn’s disease cases under infliximab (IFX) biosimilar with controls that are age- and sex-matched in terms of disease severity. Background Crohn’s disease is a relapsing, remitting condition that affects the gastrointestinal tract. One approach to management is to use biological therapy. Patients and methods This cross-sectional case-control study was carried out at the outpatient clinic of the gastroenterology and hepatology departments of the Faculty of Medicine at Menofia University and was imaged at Shebin Elkom Ophthalmology Hospital. The study included 60 participants who were divided into three groups with no ophthalmologic history or symptoms. Results Regarding slit examination findings, within group A 14 (70%) cases had eye dryness, and six (30) had allergic keratoconjunctivitis; within group B 11 (55%) cases were normal, five (25%) cases showed dryness, and three (15%) had allergic keratoconjunctivitis; and there was anterior uveitis in one (5%) patient; in group C 10 (50%) patients were normal, seven (35%) patients showed dryness, and three (15%) had allergic keratoconjunctivitis. There was a significant increase in dryness and allergic keratoconjunctivitis within group A compared with groups B and C (P=0.04). Conclusion Our study concluded that patients with moderate to severe Crohn’s disease who received IFX biosimilar had higher eye dryness, allergic keratoconjunctivitis, and longer disease duration. Therefore, the use of IFX should be limited.https://journals.lww.com/10.4103/ejos.ejos_33_24crohn’sdiseaseinfliximab biosimilarsoptical coherence tomography angiographyretinal microvasculature
spellingShingle Hesham M. El Mazar
El sayed E. El Shayeb
Asmaa M. Ebrahim
Ayatullah S.A. Motawe
Esraa S. El-Ghoubashy
Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
Journal of the Egyptian Ophthalmological Society
crohn’s
disease
infliximab biosimilars
optical coherence tomography angiography
retinal microvasculature
title Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
title_full Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
title_fullStr Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
title_full_unstemmed Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
title_short Effects of infliximab biosimilar on retinal microvasculature in Crohn’s disease patients evaluated by optical coherence tomography angiography
title_sort effects of infliximab biosimilar on retinal microvasculature in crohn s disease patients evaluated by optical coherence tomography angiography
topic crohn’s
disease
infliximab biosimilars
optical coherence tomography angiography
retinal microvasculature
url https://journals.lww.com/10.4103/ejos.ejos_33_24
work_keys_str_mv AT heshammelmazar effectsofinfliximabbiosimilaronretinalmicrovasculatureincrohnsdiseasepatientsevaluatedbyopticalcoherencetomographyangiography
AT elsayedeelshayeb effectsofinfliximabbiosimilaronretinalmicrovasculatureincrohnsdiseasepatientsevaluatedbyopticalcoherencetomographyangiography
AT asmaamebrahim effectsofinfliximabbiosimilaronretinalmicrovasculatureincrohnsdiseasepatientsevaluatedbyopticalcoherencetomographyangiography
AT ayatullahsamotawe effectsofinfliximabbiosimilaronretinalmicrovasculatureincrohnsdiseasepatientsevaluatedbyopticalcoherencetomographyangiography
AT esraaselghoubashy effectsofinfliximabbiosimilaronretinalmicrovasculatureincrohnsdiseasepatientsevaluatedbyopticalcoherencetomographyangiography